(DCPH) –
-
Form DEF 14A Deciphera Pharmaceutical For: Jun 20
-
Form 4 Deciphera Pharmaceutical For: Apr 22 Filed by: Brightstar Associates LLC
-
Form PRER14A Deciphera Pharmaceutical
-
Form PRE 14A Deciphera Pharmaceutical For: Jun 20
-
Deciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forum
-
Deciphera (DCPH) PT Raised to $16 at JPMorgan
-
Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Form 4 Deciphera Pharmaceutical For: Feb 15 Filed by: Sherman Matthew L
-
Form 4 Deciphera Pharmaceutical For: Feb 15 Filed by: Pitman Jama
-
Form 4 Deciphera Pharmaceutical For: Feb 15 Filed by: Dhanak Dashyant
-
Form 4 Deciphera Pharmaceutical For: Feb 15 Filed by: Kelly Thomas Patrick
-
Form 4 Deciphera Pharmaceutical For: Feb 15 Filed by: Martin Daniel C.
-
Form 4 Deciphera Pharmaceutical For: Feb 15 Filed by: Hoerter Steven L.
-
Form SC 13G/A Deciphera Pharmaceutical Filed by: Redmile Group, LLC
-
Form SC 13G/A Deciphera Pharmaceutical Filed by: BRAIDWELL LP
-
Form SC 13G/A Deciphera Pharmaceutical Filed by: ARMISTICE CAPITAL, LLC
-
Form SC 13G/A Deciphera Pharmaceutical Filed by: VANGUARD GROUP INC
-
Form SC 13G/A Deciphera Pharmaceutical Filed by: Flynn James E
-
Form SC 13G/A Deciphera Pharmaceutical Filed by: Brightstar Associates LLC
-
Form 4 Deciphera Pharmaceutical For: Feb 07 Filed by: Brightstar Associates LLC
-
Form S-8 Deciphera Pharmaceutical
-
Deciphera (DCPH) PT Raised to $23 at Stifel
-
Form 10-K Deciphera Pharmaceutical For: Dec 31
-
Form SC 13G/A Deciphera Pharmaceutical Filed by: GOLDMAN SACHS GROUP INC
-
Form 8-K Deciphera Pharmaceutical For: Feb 06
-
Deciphera Pharmaceuticals (DCPH) Tops Q4 EPS by 5c
-
Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2023 Financial Results
-
Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call and Webcast on February 6, 2024
-
Deciphera Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
-
Form SC 13G/A Deciphera Pharmaceutical Filed by: BlackRock Inc.
-
Form SC 13G/A Deciphera Pharmaceutical Filed by: STATE STREET CORP
-
Form 4 Deciphera Pharmaceutical For: Jan 16 Filed by: Pitman Jama
-
Form 4 Deciphera Pharmaceutical For: Jan 16 Filed by: Sherman Matthew L
-
Form 4 Deciphera Pharmaceutical For: Jan 16 Filed by: Friedman Franklin Stuart
-
Form 4 Deciphera Pharmaceutical For: Jan 16 Filed by: Kelly Thomas Patrick
-
Form 4 Deciphera Pharmaceutical For: Jan 16 Filed by: Walsh Dennis Leo
-
Form 4 Deciphera Pharmaceutical For: Jan 16 Filed by: Allen Patricia L
-
Form 4 Deciphera Pharmaceutical For: Jan 16 Filed by: Martin Daniel C.
-
Form 4 Deciphera Pharmaceutical For: Jan 16 Filed by: Squarer Ron
-
Deciphera Pharmaceuticals (DCPH) Presents Long-Term Follow-Up Results from INTRIGUE Phase 3 Clinical Study in Second-Line GIST Patients
-
Deciphera Pharmaceuticals Presents Long-Term Follow-Up Results from INTRIGUE Phase 3 Clinical Study in Second-Line GIST Patients at the 2024 American Society of Clinical Oncology Gastrointestinal Canc
-
Deciphera Pharmaceuticals (DCPH) and GENESIS Pharma Enter an Exclusive Distribution Agreement to Commercialize RIPRETINIB in 14 EU Markets
-
GENESIS Pharma Announces an Exclusive Distribution Agreement with Deciphera Pharmaceuticals to Commercialize RIPRETINIB in 14 EU Markets in Central and Eastern Europe
-
Form 8-K Deciphera Pharmaceutical For: Jan 08
-
Deciphera Pharma (DCPH) Announces Nature Medicine Publication of Results from Exploratory ctDNA Analysis from INTRIGUE Phase 3 Study
-
Deciphera Pharmaceuticals Announces Nature Medicine Publication of Results from Exploratory ctDNA Analysis from INTRIGUE Phase 3 Study Demonstrating Substantial Clinical Benefit of QINLOCK® in 2L GIS
-
Deciphera Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Form 4 Deciphera Pharmaceutical For: Dec 12 Filed by: Kelly Thomas Patrick
-
Form 4 Deciphera Pharmaceutical For: Dec 12 Filed by: Pitman Jama
-
Form 4 Deciphera Pharmaceutical For: Dec 12 Filed by: Martin Daniel C.
Back to DCPH Stock Lookup